ADC-1013

Known as: Agonistic Anti-CD40 Monoclonal Antibody ADC-1013 
A human immunoglobulin (Ig) G1 monoclonal antibody directed against the cell surface receptor CD40 with potential immunostimulatory and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
02420132015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
PURPOSE Local administration of immune-activating antibodies may increase the efficacy and reduce the immune-related adverse… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Activation of CD40 on dendritic cells increases crosspresentation of tumor antigens and as a result the number of activated tumor… (More)
Is this relevant?
2015
2015
Purpose: Local administration of immune-activating antibodies may increase the efficacy and reduce the immune-related adverse… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Stimulation of CD40 on dendritic cells to expand and activate tumor-specific T cells and generate anticancer immunity is an… (More)
  • figure 1
Is this relevant?
2014
2014
Local activation of costimulatory pathways by e.g. CD40 activation has been shown to generate powerful systemic anti-tumor… (More)
Is this relevant?
2013
2013
Local administration of immune activating antibodies may increase the efficacy and reduce the immunerelated adverse events… (More)
Is this relevant?